T cell gene therapy: Began enrollment of 40 patients for the Phase II portion of a Phase I/II trial. The trial involves pairs of identical twins, one of whom is

Cell Genesys Inc. (CEGE), Foster City, Calif. Product: T cell gene therapy Indication: AIDS Status: Began enrollment of 40 patients for the Phase II portion of a Phase I/II trial. The trial involves p...